However, we again noted no significant difference in the miRNA signature between MYB fusion positive samples with deleted 3′UT sequences and fusion-negative ACC samples that are predicted to retain these miRNA binding sites. This evidence concerns the gene MYB and adrenal cortex carcinoma.